1 not yet recruiting, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Unknown 1 |
Follow LY03017-Placebo: new trials by email Literature Review of LY03017-Placebo trials Research Report on LY03017-Placebo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017 LY03017, LY03017-Placebo - Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis, Hallucinations and Delusions Associated With Parkinson Disease Psychosis | Phase 1 | Not yet recruiting | Luye Pharma Group Ltd. | 40 | 2025-05-01 | 2025-05-20 |
| A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017 LY03017, LY03017-Placebo - Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis, Hallucinations and Delusions Associated With Parkinson Disease Psychosis | Phase 1 | Unknown | Luye Pharma Group Ltd. | 60 | 2024-05-10 | 2024-04-29 |
Hallucinations (2)
China (2)